EUVIMEDEUVIMED entdecken
CrossrefInfokarte

In vitro antitumor effect of essential oil of Ñandypá (Genipa americana L.) on human pancreatic carcinoma cell lines (MIA PaCa2)

Eva R. Montiel Fernández, Jorge L M. Ruíz

Medicina Clínica y Social · 2026

DOI: 10.52379/mcs.v10.699 ↗
AbstractBibliografische Angaben

Abstract

Introduction: South American biodiversity offers a source of new therapeutic compounds. Cancer remains a major global health issue with high morbidity and mortality. ñandypa (Genipa americana L.), a medicinal plant with various reported properties, was tested for citotoxic activity of the essential oil from their leaves. Objective: to determine the in vitro antitumor effect of an essential oil derived from ñandypa on human pancreatic carcinoma cell lines (MIA PaCa2). Methodology:Essential oils from G. americana leaves were obtained via hydrodistillation, and their chemical composition was analyzed using Gas Chromatography-Flame Ionization Detection-Mass Spectrometry (GC-FID-MS). Pancreatic tumor cells and normal fibroblast cells were then tested for antitumor activity. The cells were treated with serial dilutions of the essential oil (0.1%, 0.5%, 1%, 1.5%, 5%, and 10%). Cell viability was measured using an MTT assay, with results read on a spectrophotometer at 570nm and 630nm. Results: GC-FID-MS analysis revealed the oil's primary components were alcohols (17.83%), aldehydes (9.58%), and esters (5.18%). Exposure to the oil for four hours resulted in a high rate of tumor cell mortality, with the effect being more pronounced at higher concentrations. Importantly, the oil was not found to be toxic to normal cells (MRC-5). Conclusion: The essential oil of Genipa americana L. exhibits significant, dose-dependent antitumor activity against human pancreatic carcinoma cells (MIA PaCa-2). Notably, it showed no toxicity toward normal human fibroblast cells (MRC-5). These findings, supported by the presence of bioactive compounds like BHT, ?-pinene, and ?-caryophyllene, suggest its potential as a selective therapeutic agent for pancreatic cancer.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →